Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin.
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.06.018
Abstract: Bacillus Calmette-Guérin (BCG) is used as first-line intravesical therapy following tumor resection of non-muscle-invasive bladder cancer. Primary producers of BCG announced shortages within the last decade, leading to a worldwide shortage. We review the literature… read more here.
Keywords: bacillus calmette; shortage; manufacturing market; calmette rin ... See more keywords